139 related articles for article (PubMed ID: 12649132)
1. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD2 monoclonal antibody, MEDI-507.
Zhang Z; Zhang M; Ravetch JV; Goldman C; Waldmann TA
Blood; 2003 Jul; 102(1):284-8. PubMed ID: 12649132
[TBL] [Abstract][Full Text] [Related]
2. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H.
Zhang Z; Zhang M; Goldman CK; Ravetch JV; Waldmann TA
Cancer Res; 2003 Oct; 63(19):6453-7. PubMed ID: 14559836
[TBL] [Abstract][Full Text] [Related]
3. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
4. Activating Fc receptors are required for antitumor efficacy of the antibodies directed toward CD25 in a murine model of adult t-cell leukemia.
Zhang M; Zhang Z; Garmestani K; Goldman CK; Ravetch JV; Brechbiel MW; Carrasquillo JA; Waldmann TA
Cancer Res; 2004 Aug; 64(16):5825-9. PubMed ID: 15313926
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy for adult T-cell leukemia-xenografted mice: flavopiridol and anti-CD25 monoclonal antibody.
Zhang M; Zhang Z; Goldman CK; Janik J; Waldmann TA
Blood; 2005 Feb; 105(3):1231-6. PubMed ID: 15383455
[TBL] [Abstract][Full Text] [Related]
6. Effective treatment of a murine model of adult T-cell leukemia using depsipeptide and its combination with unmodified daclizumab directed toward CD25.
Chen J; Zhang M; Ju W; Waldmann TA
Blood; 2009 Feb; 113(6):1287-93. PubMed ID: 18948574
[TBL] [Abstract][Full Text] [Related]
7. Effective treatment of a murine model of adult T-cell leukemia using 211At-7G7/B6 and its combination with unmodified anti-Tac (daclizumab) directed toward CD25.
Zhang Z; Zhang M; Garmestani K; Talanov VS; Plascjak PS; Beck B; Goldman C; Brechbiel MW; Waldmann TA
Blood; 2006 Aug; 108(3):1007-12. PubMed ID: 16569769
[TBL] [Abstract][Full Text] [Related]
8. The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia.
Waldmann TA; White JD; Goldman CK; Top L; Grant A; Bamford R; Roessler E; Horak ID; Zaknoen S; Kasten-Sportes C
Blood; 1993 Sep; 82(6):1701-12. PubMed ID: 8400227
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.
Hartmann F; Horak EM; Garmestani K; Wu C; Brechbiel MW; Kozak RW; Tso J; Kosteiny SA; Gansow OA; Nelson DL
Cancer Res; 1994 Aug; 54(16):4362-70. PubMed ID: 8044783
[TBL] [Abstract][Full Text] [Related]
10. Markedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia.
Chen J; Pise-Masison CA; Shih JH; Morris JC; Janik JE; Conlon KC; Keating A; Waldmann TA
Blood; 2013 Mar; 121(11):2029-37. PubMed ID: 23321252
[TBL] [Abstract][Full Text] [Related]
11. Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia.
Tanaka H; Fujiwara H; Ochi F; Tanimoto K; Casey N; Okamoto S; Mineno J; Kuzushima K; Shiku H; Sugiyama T; Barrett AJ; Yasukawa M
Clin Cancer Res; 2016 Sep; 22(17):4405-16. PubMed ID: 27091408
[TBL] [Abstract][Full Text] [Related]
12. Anti-IL-2 receptor monoclonal antibody (anti-Tac) treatment of T-cell lymphoma.
Waldmann TA
Important Adv Oncol; 1994; ():131-41. PubMed ID: 8206486
[TBL] [Abstract][Full Text] [Related]
13. Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.
Berkowitz JL; Janik JE; Stewart DM; Jaffe ES; Stetler-Stevenson M; Shih JH; Fleisher TA; Turner M; Urquhart NE; Wharfe GH; Figg WD; Peer CJ; Goldman CK; Waldmann TA; Morris JC
Clin Immunol; 2014 Dec; 155(2):176-87. PubMed ID: 25267440
[TBL] [Abstract][Full Text] [Related]
14. Combination of 9-aminoacridine with Campath-1H provides effective therapy for a murine model of adult T-cell leukemia.
Ju W; Zhang M; Petrus M; Maeda M; Pise-Masison CA; Waldmann TA
Retrovirology; 2014 Jun; 11():43. PubMed ID: 24890041
[TBL] [Abstract][Full Text] [Related]
15. Effective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptors.
Zhang M; Yao Z; Zhang Z; Garmestani K; Goldman CK; Ravetch JV; Janik J; Brechbiel MW; Waldmann TA
Blood; 2006 Jul; 108(2):705-10. PubMed ID: 16551968
[TBL] [Abstract][Full Text] [Related]
16. A role for CD2 antibodies (BTI-322 and its humanized form) in the in vivo elimination of human T lymphocytes infiltrating an allogeneic human skin graft in SCID mice: an Fcgamma receptor-related mechanism involving co-injected human NK cells.
Snanoudj R; Rouleau M; Bidère N; Carmona S; Baron C; Latinne D; Bazin H; Charpentier B; Senik A
Transplantation; 2004 Jul; 78(1):50-8. PubMed ID: 15257038
[TBL] [Abstract][Full Text] [Related]
17. Antibody therapy for Adult T-cell leukemia-lymphoma.
Ishida T; Ueda R
Int J Hematol; 2011 Nov; 94(5):443-52. PubMed ID: 21993874
[TBL] [Abstract][Full Text] [Related]
18. Comparison of anti-Tac and anti-transferrin receptor-conjugated liposomes for specific drug delivery to adult T-cell leukemia.
Hege KM; Daleke DL; Waldmann TA; Matthay KK
Blood; 1989 Nov; 74(6):2043-52. PubMed ID: 2679914
[TBL] [Abstract][Full Text] [Related]
19. Pretargeting radioimmunotherapy of a murine model of adult T-cell leukemia with the alpha-emitting radionuclide, bismuth 213.
Zhang M; Yao Z; Garmestani K; Axworthy DB; Zhang Z; Mallett RW; Theodore LJ; Goldman CK; Brechbiel MW; Carrasquillo JA; Waldmann TA
Blood; 2002 Jul; 100(1):208-16. PubMed ID: 12070029
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac.
Waldmann TA; White JD; Carrasquillo JA; Reynolds JC; Paik CH; Gansow OA; Brechbiel MW; Jaffe ES; Fleisher TA; Goldman CK; Top LE; Bamford R; Zaknoen E; Roessler E; Kasten-Sportes C; England R; Litou H; Johnson JA; Jackson-White T; Manns A; Hanchard B; Junghans RP; Nelson DL
Blood; 1995 Dec; 86(11):4063-75. PubMed ID: 7492762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
